Recent News

By Category: Policy & Initiatives

NSABB wants clarifications in Fouchier’s H5N1 manuscript

(CIDRAP News) The US National Science Advisory Board for Biosecurity (NSABB) says in a new report that one of two controversial H5N1 avian flu studies needs some clarifications before publication and that some additional information the board heard from the lead author should not be included in the paper. Over the weekend the NSABB released  Read More »

Webcast Hearing TODAY – Taking Measure of Countermeasures (Part 3): Protecting the Protectors

Washington, D.C. – The Homeland Security Subcommittee on Emergency Preparedness, Response, and Communications, chaired by Rep. Gus Bilirakis (R-FL), will hold a hearing entitled “Taking Measure of Countermeasures (Part 3): Protecting the Protectors” at 2 p.m. in Room 311 Cannon House Office Building. At tomorrow’s hearing, the Subcommittee will continue its examination of medical countermeasures for  Read More »

Could Bird Flu Be a Weapon? Dutch Law May Keep Flu Research Bottled Up

(Discover Magazine) But in a new, international twist, one of the papers is encountering another obstacle: NPR reported that the Netherlands-based team behind one of the studies is being stifled by Dutch law, which limits the export of technology that could be weaponized. So now there are two main questions about whether the flu research  Read More »

Govt takes preventive steps against ‘foot and mouth disease’

(Financial Express Bangladesh) The government has, for the first time, decided to introduce ‘special zoning system’ to fight ‘foot and mouth disease’ (FMD) in cows and help boost the country’s export of beef, officials told the FE. The country’s export promotion office along with other relevant government agencies took a decision to this effect as  Read More »

Scientist Blasts Feds on Bird Flu Briefing

(Global Security Newswire) A member of the National Science Advisory Board for Biosecurity has suggested that a federal agency rigged the panel’s deliberations on two avian influenza virus studies last month so that the group would endorse unredacted release of the research, the Center for Infectious Disease Research and Policy reported on Friday. The board  Read More »